Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia
Cartellieri, Marc Michalk, Irene von Bonin, Malte Krueger, Thomas Stamova, Slava Koristka, Stefanie Arndt, Claudia Feldmann, Anja Schmitz, Marc Wermke, Martin Lindemann, Dirk Bornhaeuser, Martin Ehninger, Gerhard Bachmann, Michael
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.